North America Transplant Diagnostics Market, By Product and Services (Reagents and Consumables, Instruments, Software and Services), Organ Type (Kidney, Liver, Heart, Lung, Pancreas, Others), Technology (Molecular Assays, Non-Molecular Assays), Transplant Type (Solid Organ Transplant, Stem Cell Transplant, Soft Tissue Transplant), Application (Diagnostic Applications, Research Applications), End User (Independent Reference Laboratories, Hospitals and Transplant Centers, Research Laboratories and Academic Institutes), Country (U.S., Canada, Mexico) Industry Trends and Forecast to 2028
North America transplant diagnostics market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market to account to USD 2718.04 million by 2028 and will grow at a CAGR of 6.54% in the above mentioned forecast period.
The rapidly increasing public and private funding for target research activities is largely impacting the growth rate of the target market. On other hand, the rising demand for transplants has always been higher than the supply of organs which further propels the high adoption rate of the market for North America transplant diagnostics. Also the rising geriatric population, increasing number of soft tissue, solid and stem cell based transplantation are also fueling the demand of the North America transplant diagnostics market over the forecast period of 2021 to 2028. Moreover, technological advancements in the field of transplant diagnostics, rising prevalence of infectious diseases, growing number of transplant procedures and growth in robot assisted laboratory automation of diagnostic procedures are also adding thrust to the market growth. While, the high procedural cost of NGS- and PCR-based diagnostic assays as well as the limited reimbursements for target procedures are expected to impede the growth of the North America transplant diagnostics market in the above mentioned forecast period. Also, increasing application of HLA typing products in clinical diagnostics, constant reduction in average cost of gene sequencing, improving healthcare infrastructure in emerging countries, and increasing installation base of PCR and NGS instruments are some of the key determinants driving the growth of the North America transplant diagnostic market.
The high adoption of cross-matching and chimerism testing during pre- and post-transplantation and increasing public awareness regarding organ donation and transplantation which will further accelerate the expansion of the North America transplant diagnostics market and are also are offering significant growth opportunities for the market in the forecast period of 2021 to 2028. Furthermore, the procedural and technical limitations coupled with donor recipient screening will challenge the growth of the North America transplant diagnostics market.
This North America transplant diagnostics market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on North America transplant diagnostics market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
North America Transplant Diagnostics Market Scope and Market Size
North America transplant diagnostics market is segmented on the basis of product and services, organ type, technology, transplant type, application and end user. The growth amongst these segments will help you analyze meager growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- On the basis of product and services, the North America transplant diagnostics market is segmented into reagents and consumables, instruments and software and services.
- Based on organ type, the North America transplant diagnostics market is segmented into kidney, liver, heart, lung, pancreas and others.
- On the basis of technology, the North America transplant diagnostics market is segmented into molecular assays and non-molecular assays. Molecular assays have further been segmented into PCR-based molecular assays and sequencing-based molecular assays. PCR-based molecular assays are further sub-segmented into real-time PCR, sequence-specific primer-PCR, Sequence-specific oligonucleotide-PCR and others. Sequencing-based molecular assays are further sub-segmented into sanger sequencing, next-generation sequencing and other. Non-molecular assays have further been segmented into serological assays and mixed lymphocyte culture (MLC) testing.
- On the basis of transplant type, the North America transplant diagnostics market is segmented into solid organ transplant, stem cell transplant and soft tissue transplant. Solid organ transplant is further segmented into kidney transplant, liver transplant, heart transplant, lung transplant, pancreas transplant and other.
- The North America transplant diagnostics market is also segmented on the basis of application into diagnostic applications and research applications. Diagnostic applications have further been segmented into pre-transplantation diagnostics and post-transplantation diagnostics. Pre-transplantation diagnostics are further sub-segmented into infectious disease testing, histocompatibility testing and blood profiling.
- On the basis of end user, the North America transplant diagnostics market is segmented into independent reference laboratories, hospitals and transplant centers and research laboratories and academic institutes.
North America Transplant Diagnostics Market Country Level Analysis
North America transplant diagnostics market is analyzed and market size insights and trends are provided by country, product and services, organ type, technology, transplant type, application and end user as referenced above.
The countries covered in the North America transplant diagnostics market report are U.S., Canada and Mexico in North America.
U.S. leads the North America transplant diagnostics market because of certain factors such as highly developed healthcare infrastructure and the easy availability of skilled professionals.
The country section of the North America transplant diagnostics market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of regional brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
North America transplant diagnostics market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for North America transplant diagnostics market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the North America transplant diagnostics market. The data is available for historic period 2010 to 2019.
Competitive Landscape and North America Transplant Diagnostics Market Share Analysis
North America transplant diagnostics market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, regional presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to North America transplant diagnostics market.
The major players covered in the North America transplant diagnostics market report are Luminex Corporation., Hologic, Inc., GenDx, Abbott, Illumina, Inc, Omixon Inc., F. Hoffmann-La Roche Ltd, BD, Bio-Rad Laboratories, Inc., CareDx, Inc., Thermo Fisher Scientific Inc., and Immucor, Inc., among others. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
Customization Available : North America Transplant Diagnostics Market
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.